In conclusion, the results of this study imply that application of HBOT, via altering SOD2 ‎expression, may attenuate imbalance between oxidants and antioxidants that occurs after brain ‎injury, and in that way contributes to the maintenance of pro-/antioxidant homeostasis. The gene discussed is SOD2; the disease is brain injury.